AAHPM opposes opioid labeling petition at FDA hearing

02/8/2013 | MedPage Today (free registration)

The American Association of Hospice and Palliative Medicine was among the groups represented at an FDA hearing on a petition on the labeling of opioid drugs. AAHPM and other groups said the proposal could block access to opioid drugs for patients with legitimate pain and that there are challenges in implementing rules that seek to distinguish cancer pain and noncancer pain due to the long-term complications of the disease.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN